GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shaanxi Panlong Pharmaceutical Group Ltd (SZSE:002864) » Definitions » 14-Day RSI

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) 14-Day RSI : 55.72 (As of May. 28, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shaanxi Panlong Pharmaceutical Group 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-28), Shaanxi Panlong Pharmaceutical Group's 14-Day RSI is 55.72.

The industry rank for Shaanxi Panlong Pharmaceutical Group's 14-Day RSI or its related term are showing as below:

SZSE:002864's 14-Day RSI is ranked worse than
76.71% of 1142 companies
in the Drug Manufacturers industry
Industry Median: 46.675 vs SZSE:002864: 55.72

Competitive Comparison of Shaanxi Panlong Pharmaceutical Group's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Shaanxi Panlong Pharmaceutical Group's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shaanxi Panlong Pharmaceutical Group's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shaanxi Panlong Pharmaceutical Group's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Shaanxi Panlong Pharmaceutical Group's 14-Day RSI falls into.



Shaanxi Panlong Pharmaceutical Group  (SZSE:002864) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shaanxi Panlong Pharmaceutical Group  (SZSE:002864) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Shaanxi Panlong Pharmaceutical Group 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Shaanxi Panlong Pharmaceutical Group's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Shaanxi Panlong Pharmaceutical Group (SZSE:002864) Business Description

Traded in Other Exchanges
N/A
Address
2801 Baliu 2nd Road, Modern Textile Ind Park Baqiao, Xian, CHN, 710025
Shaanxi Panlong Pharmaceutical Group Ltd operates as a pharmaceuticals company. It manufactures and markets drugs for the treatment of traumatology, cardiovascular and cerebrovascular, respiratory, pediatrics, and hepatobiliary.
Executives
Zhang De Zhu Directors, executives
Liu Zhao Supervisors
Jian Bao Liang Supervisors
Zhang Zhi Hong Directors, executives
Zhang Shui Ping Director
Wu Jie Directors, Directors, and Executives
Zhu Feng Ming Executives
Zhu Wen Feng Director
Xie Xiao Feng Director
Xie Xiao Lin Directors, executives

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) Headlines

No Headlines